Anxiety Disorders

by Nutt, David J.; Ballenger, James C.

• ISBN13: 9780632059386
• ISBN10: 0632059389
• Format: Hardcover
• Copyright: 2003-02-04
• Publisher: Wiley-Blackwell

Summary

Rapid developments in recent years in basic science and pharmacology has greatly increased understanding of the causes of anxiety disorders. This has led to a large number of new drug treatments from the pharmaceutical industry. This book makes sense of these advances and presents a coherent account of diagnosis and management from the clinical point of view.Chapters are in the form of surveys and digests of the recent literature and are interspersed with clinical guidelines, diagnostic and therapeutic points and are well illustrated.

Table of Contents

Contributors	vii
Preface	xi
Part 1: Introduction
Conceptual Antecedents of the Anxiety Disorders	3	(22)
R.D. Marshall
D.F. Klein
Part 2: Symptoms and Syndromes
Relationships Among Anxiety Disorders: Patterns and Implications	25	(14)
H.-U. Wittchen
Y. Lecrubier
K. Beesdo
A. Nocon
Panic Disorder: Symptoms and Syndromes	39	(12)
S. S. Sinha
J. Gorman
Generalized Anxiety Disorder	51	(14)
J. Monnier
O. Brawman-Mintzer
Post-traumatic Stress Disorder	65	(18)
S.A.M. Rauch
E.B. Foa
Obsessive-compusive Disorder	83	(12)
J. Zohar
Y. Sasson
M. Chopra
R. Amiaz
N. Nakash
Social Anxiety Disorder	95	(30)
P.L. du Toit
D.J. Stein
Sleep Aspects of Anxiety Disorders	125	(10)
T.A. Mellman
Childhood Antecedents of Adult Anxiety Disorders	135	(28)
S.J. Fredman
D.R. Hirshfeld-Becker
J.W. Smoller
J.F. Rosenbaum
Anxiety and Schizophrenia	163	(20)
R.A. Emsley
D.J. Stein
Part 3: Mechanisms
Neurochemical Aspects of Anxiety	183	(18)
S.V. Argyropoulos
D.J. Nutt
Brain Imaging and Anxiety Disorders	201	(28)
A.L. Malizia
Genetic Dissection of Anxiety and Related Disorders	229	(22)
K.P. Lesch
Respiration and Anxiety	251	(18)
E. Griez
G. Perna
Pharmacological Challenge Agents in Anxiety	269	(28)
J. Swain
D. Koszycki
J. Shlik
J. Bradwejn
Panic Disorder and Medical Illness	297	(18)
T.S. Zaubler
W. Katon
Part 4: Treatments
Benzodiazepines	315	(24)
C. Faravelli
S. Rosi
E. Truglia
Selective Serotonin Reuptake Inhibitors in the Treatment of the Anxiety Disorders	339	(24)
J.C. Ballenger
Treatment of Anxiety Disorders with Tricyclic Antidepressants	363	(18)
R. Rosenberg
Buspirone in the Treatment of Anxiety Disorders	381	(18)
K. Rickels
S. Khalid-Khan
M. Rynn
Antihistamines in the Treatment of Psychic and Somatic Anxiety States	399	(12)
M.M.M.P. Van Moffaert
Anxiety Disorders: New Antidepressants	411	(14)
R.B. Hidalgo
J.R.T. Davidson
Cognitive Behavioral Treatment of Anxiety Disorders	425	(20)
S.A. Falsetti
A. Combs-Lane
J.L. Davis
Exposure Therapy in the Treatment of Anxiety Disorders	445	(18)
S.P. Cahill
E.B. Foa
Anxiety Disorders: Alternative Drug Treatments	463	(18)
N. Laufer
S. Gur
R. Gross-Isseroff
A. Weizman
Physical Treatments	481	(10)
T.E. Schlaepfer
B.D. Greenberg
Herbal Therapy and Anxiety	491	(10)
M. Bourin
Part 5: Conclusion
Anxiety Disorders: Current Needs and Future Prospects	501	(10)
D. Nutt
J. Ballenger
Index	511